+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Serum interleukin-6 and beta-2-microglobulin levels in aggressive lymphoma and in advanced multiple myeloma patients Correlation with disease activity and other prognostic parameters



Serum interleukin-6 and beta-2-microglobulin levels in aggressive lymphoma and in advanced multiple myeloma patients Correlation with disease activity and other prognostic parameters



Blood 86(10 SUPPL 1): 826A




(PDF emailed within 1 workday: $29.90)

Accession: 033360633

Download citation: RISBibTeXText


Related references

Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters. Annals of Hematology 62(2-3): 54-58, 1991

Prognostic significance of pretreatment serum beta 2-microglobulin levels in multiple myeloma. European Journal of Cancer and Clinical Oncology 19(10): 1361-1364, 1983

Correlation and prognostic value of serum soluble ICAM-1, beta-2 microglobulin, and IL-2alphaR levels in non-Hodgkin's lymphoma. Leukemia and Lymphoma 33(5-6): 551-558, 1999

The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients. Terapevticheskii Arkhiv 68(10): 28-31, 1996

Serum interleukin-10 levels in patients affected with multiple-myeloma - correlation with the monoclonal component and disease progression. International Journal of Oncology 6(6): 1189-1192, 1995

Prognostic value of serum beta 2 microglobulin s b2m in multiple myeloma. Clinical & Investigative Medicine 14(4 SUPPL): A58, 1991

Correlation of serum IL-2, IL-6 and IL-10 levels with International Prognostic Index in patients with aggressive non-Hodgkin's lymphoma. American Journal of Clinical Oncology 25(6): 570-572, 2002

Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis. Journal of Neurology 241(2): 108-114, 1993

Serum beta 2-microglobulin levels in multiple myeloma and monoclonal gammapathy of undetermined significance: a clinical study of 55 patients. La Ricerca in Clinica E in Laboratorio 16(1): 53-58, 1986

Are the high serum interleukin-6 and vascular endothelial growth factor levels useful prognostic markers in aggressive non-hodgkin lymphoma patients?. Turkish Journal of Haematology 32(1): 21-28, 2015

Bone marrow histology and serum beta 2 microglobulin in multiple myeloma--a new prognostic strategy. European Journal of Haematology. Supplementum 51: 88-98, 1989

Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myeloma. Rivista Europea Per le Scienze Mediche E Farmacologiche 12(4-5): 233-238, 1990

Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levels. Acta Universitatis Palackianae Olomucensis Facultatis Medicae 130: 201-212, 1991

Clinical significance of correction of serum beta 2-microglobulin levels for serum creatinine in multiple myeloma. Acta Universitatis Palackianae Olomucensis Facultatis Medicae 131: 257-264, 1991

Unexpected normal serum beta-microglobulin (B2M) levels in multiple myeloma. Anticancer Research 7(3 Pt B): 513-515, 1987